< PreviousABSTRACTS20 Abstracts Nr & Co-authors Presentation Nr TitlePresenterDateTime Inter- vention LocationSession Code Session TypeSessionSession Time 2431O0155 Metagenomic and transcriptomic analysis of the virulence-related pathways in tolerant and persis- ter cells of Klebsiella pneumoniae Gulı̇n Ozcan15-04-202311:00Hall POS033 1-hour Oral Session Intracellular bacterial infections and persistence 11:00 Gulı̇N Ozcan (1, 2), Cansel Vatansever (1), Jale Boral (1, 2), Guz Ekinci (1, 2), Sirin Menekse (3), Mehmet Gonen (1, 4), Fusun Can (1, 5) - (1) Koç University Işbank Center For Infectious Diseases (Kuiscid), Turkey, (2) Koç University, Graduate School Of Health Sciences (Gshs), Turkey, (3) Infectious Diseases And Clinical Microbiology Department, Kartal Koşuyolu Training And Research Hospital, Turkey, (4) Koç University, College Of Engineering, Department Of Industrial Engineering, Turkey, (5) Koç University, School Of Medicine, Department Of Medical Microbiology, Turkey 2432P1435 Changes in invasive pneumococcal disease in patients over 65 years of age after introduction of antipneumococcal vaccination for Polish children Patrycja Ronki- ewicz 16-04-202312:00 Poster Area PS015 Poster Session 2f. Community acquired nervous system and other multi-system bacterial infections(incl. epide- miology, clinical, imaging, treat- ment & prevention) 12:00 Patrycja Ronkiewicz, Alicja Kuch, Izabela Wróbel-Pawelczyk, Marlena Kiedrowska, Agnieszka Gołębiewska, Kinga Błaszczyk, Waleria Hryniewicz, Anna Skoczyńska - (1) National Medicines Institute, Poland 2433P1152 Implementation of an interdisciplinary endocardi- tis board at the University Hospital Schleswig-Hol- stein (UKSH), Campus Kiel: first results on risk factors and lethality Anette Fried- richs 16-04-202312:00 Poster Area PS011 Poster Session 2b. Severe sepsis, bacteraemia & endocarditis (incl. epidemiology, diagnosis, host bio-markers, treat- ment and outcome prediction) 12:00 Daniel Pape (1), Johanne Frank (2), Christina Grothusen (3, 4), Michael Jüptner (5), Bibiane Steinborn (6), Mattis Derner (3), Lasse Kaack (2), Johannes Janke (3), Christina Kujat (1), Ulf Lützen (7), Alexander Thiem (3), Bernd Panholzer (3), Derk Frank (2), Anette Friedrichs (1) - (1) Department Of Internal Medicine I, Infectious Diseases, University Hospital Schleswig-Holstein, Campus Kiel, Germany, (2) Department Of Internal Medicine Iii, Cardiology, University Hospital Schleswig-Holstein, Campus Kiel, Germany, (3) Department Of Cardiovascular Surgery, University Hospital Schleswig-Holstein, Campus Kiel, Germany, (4) Department Of Internal Medicine I, St. Johannes Hospital, Germany, (5) Department Of Nuclear Medicine, Molecular Imaging Diagnostics And Therapy, University Hospital Schleswig-Holstein, Campus Kiel, Germany, (6) Hospital Pharmacy, University Hospital Schleswig-Holstein, Campus Kiel, Germany, (7) Department Of Nuclear Medicine And Molecular Imaging Diagnostics And Therapy, University Hospital Schleswig-Holstein, Campus Kiel, Germany 2434E1234 Correlation of persisting bacteraemia and compli- cated Staphylococcus aureus infection: a retros- pective cohort study Martin Strömdahl 18-04-202311:12Arena 1EF255 1-hour ePoster Flash Session Current topics in Gram-positive cocci 11:00 Martin Strömdahl (1), Johan Ursing (1, 2), Charlotta Millbourn (1), Magnus Hedenstierna (1), Anna Westman (1, 3) - (1) Department Of Infectious Diseases, Danderyd Hospital, Sweden, (2) Department Of Clinical Sciences, Karolinska Institutet, Danderyd Hospital, Sweden, (3) Department Of Microbiology, Karolinska University Hospital, Sweden 2435P0042 Effects of subinhibitory concentrations of nafcillin, vancomycin, ciprofloxacin, and rifampin on biofilm formation of methicillin-resistant Staphylococcus aureus Oh-Hyun Cho15-04-202312:00 Poster Area PS018 Poster Session 3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives 12:00 Oh-Hyun Cho (1), Sun In Hong (1), Yu-Mi Lee (2), Ki-Ho Park (2), Mi Suk Lee (2) - (1) Gyengsang National University Changwon Hospital, Korea, Republic Of, (2) Kyung Hee University Hospital, Korea, Republic Of 2436P1462 Escherichia coli ST1193 can also kill animals: invasi- ve infection in a seal of the North Sea Isidro Gar- cía-Meniño 16-04-202312:00 Poster Area PS016 Poster Session 2g. Zoonotic bacterial infections (incl. foodborne, waterborne and vector-borne pathogens, veteri- nary microbiology and One Health aspects, excl. AMR) 12:00 Isidro García-Meniño (1, 2), Claudia Jäeckel (1), Nicole Roschanski (3), Katharina Kramer (3), Hammerl Jens André (1), Azucena Mora (2) - (1) German Federal Institute For Risk Assessment (Bfr), Germany, (2) Universidade De Santiago De Compostela (Usc), Spain, (3) Landeslabor Schleswig Holstein, Geschäftsbereich, Germany 2437P3490 Rapid geographical source attribution of Salmo- nella enterica serovar Enteritidis genomes using hierarchical maChina learning Sion Bayliss18-04-202312:00 Poster Area PS079 Poster Session 11d. Digital health and infection (incl. AI, data mining, informatics) 12:00 Sion Bayliss (1), Rebecca Locke (2, 3), Claire Jenkins (4), Marie Chattaway (4), Timothy Dallman (5), Lauren Cowley (2) - (1) Bristol Veterinary School, University Of Bristol, United Kingdom, (2) Milner Centre For Evolution, Life Sciences Department, University Of Bath, United Kingdom, (3) Genomic Laboratory Hub (Glh), Addenbrooke’S Hospital, Cambridge University Hospitals Nhs Foundation Trust, United Kingdom, (4) Gastrointestinal Reference Services, Uk Health Security Agency, United Kingdom, (5) Institute For Risk Assess ment Sciences (Iras), Utrecht University, Netherlands 2438P1772 High-throughput optical DNA mapping for bacte- rial diagnostics Radhika Nambannor Kunnath 16-04-202312:00 Poster Area PS030 Poster Session 4e. Strain typing and surveillance (incl. molecular, genomic and other advanced methods) 12:00 Radhika Nambannor Kunnath (1), Sriram Kesarimangalam (1), Marie Wrande (2), Linus Sandegren (2), Anna Johnning (1), Erik Kristiansson (1), Fredrik Westerlund (1) - (1) Chalmers University Of Technology, Sweden, (2) Uppsala University, Sweden 2441P1991 Molecular detection of dermatophytes: compari- son of two diagnostic methods Annaleena Johanna Paja- nder 16-04-202312:00 Poster Area PS043 Poster Session 6b. Diagnostic mycology (incl. traditional, molecular and other methods) 12:00 Annaleena Johanna Pajander, Inka Harju, Riikka Österback, Kaisu Rantakokko-Jalava - (1) Clinical Microbiology, Laboratory Division, Turku University Hospital, Finland 2442P2765 Using CMIS compares the willingness factors to remain in current job among the hospital staff in variance of job title: specially responsible CO- VID-19 epidemic prevention hospital Chen Chii-Shya17-04-202312:00 Poster Area PS092 Poster Session 12k. Other societal aspects (incl. economics, mental health) 12:00 Chen Chii-Shya, Ian-Horng Chen - (1) Taipei City Hospital; National; University Of Nursing And Health Sciences.Taipei, Taiwan, R.O.C., Taiwan, Republic Of China 2444P0555 Molecular characterisation of ceftazidime/avibac- tam-resistant in vitro-derived mutants from clinical isolates of Klebsiella pneumoniae producing OXA- 48-like carbapenemases Tania Blan- co-Martín 15-04-202312:00 Poster Area PS022 Poster Session 3e. Resistance detection / pre- diction approaches (rapid and/ or molecular assays, resistome analysis, inference methods) 12:00 Tania Blanco-Martín (1, 2), Marta Hernández-García (3, 4), Julia Guzmán-Puche (1, 2, 3), Montserrat Muñoz-Rosa (1, 2), Cristina Elías-López (2, 3), Jorge Arca-Suárez (3, 5), Manuel Causse (1, 2, 3), Germán Bou (3, 5), Rafael Cantón (3, 4), Luis Martínez-Martínez (1, 2, 3) - (1) Microbiology Unit, Reina Sofía University Hospital, Spain, (2) Maimonides Institute Of Biomedical Research Of Cordoba (Imibic), Spain, (3) Spanish Network For Research In Infectious Diseases (Reipi) And Ciber De Enfermedades Infecciosas (Ciberinfec), Insti tuto De Salud Carlos Iii, Spain, (4) Microbiology Unit, Ramón Y Cajal University Hospital And Ramón Y Cajal Institute For Health Reasearch (Iricys), Spain, (5) Microbiology Unit, Complexo Hospitalario Universitario And Instituto De Investigación Biomédica A Coruña (Inibic), Spain 2447P0353 Evaluation of three methods to detect in vitro ceftazidime/avibactam and aztreonam synergy in carbapenem resistant metallo-β-lactamase-produ- cing Enterobacterales Barend Mitton15-04-202312:00 Poster Area PS020 Poster Session 3c. Susceptibility testing methods (incl. assay validation, phenotypic assays and comparative studies, excl. TB) 12:00 Barend Mitton, Chanel Kingsburgh, Jennifer Coetzee, Xoliswa Poswa, Pieter Ekermans, Kathy-Anne Strydom - (1) Department Of Medical Microbiology, Ampath National Reference Laboratory, South Africa 2448E0171 A new protocol for bacterial identification by MAL- DI-TOF directly from positive blood cultures Cidália Pina-Vaz15-04-202311:12Arena 3EF035 1-hour ePoster Flash Session Improving bloodstream infection diagnostics 11:00 Sara Cruz (1), David Abreu (2), Rosário Gomes (2), Inês Martins-Oliveira (2, 1), Ana Silva-Dias (2, 1, 3), Blanca Perez-Viso (4, 5), A. G. Rodrigues (1, 2, 3), António Sarmento (6), Rafael Cantón (4, 5), Cidália Pina-Vaz (1, 2, 3) - (1) Division Of Microbiology, Department Of Pathology, Faculty Of Medicine, University Of Porto, Portugal, (2) Fastinov Sa, Portugal, (3) Cintesis-Center For Health Technology And Services Research, Faculty Of Medicine Of The University Of Porto, Portugal, (4) Servicio De Microbiología, Hospital Universitario Ramón Y Cajal And Instituto Ramón Y Cajal De Investigación Sanitaria (Irycis), Spain, (5) Ciber De Enfermedades Infecciosas, Instituto De Salud Carlos Iii, Spain, (6) Centro Hospitalar De São João, Department Of Infectious Diseases, Portugal 2449P0227 Impact of COVID-19 pandemic on antibiotic re- sistance Lal Sude Gücer15-04-202312:00 Poster Area PS019 Poster Session 3b. Resistance surveillance and epidemiology: Gram-negatives 12:00 Lal Sude Gücer (1, 2, 3), Fatihan Pinarlik (1, 3), Emine Coşkun (4), Nuran Sari (5), Elif Ateş (5), Merve Çağlar (6), Şevval Özen (6), Begüm Nalça Erdin (7), Şirin Menekşe (8), Özlem Mete (9), Kübra Koçak (9), Ezgi Gülten (10), Zeynep Ceren Karahan (11), Alpay Azap (10), Ilkay Karaoğlan (9), Mehtap Aydin (6), Özlem Azap (5), Murat Kutlu (4), Refath Farzana (12), Timothy Walsh (12), Önder Ergönül (1, 2) - (1) Koç University Işbank Center For Infectious Diseases, Turkey, (2) Koç University Department Of Infectious Diseases And Clinical Microbiology, Turkey, (3) Koç University Graduate School Of Health Sciences, Turkey, (4) Pamukkale University Hospital Department Of Infectious Diseases And Clinical Microbiology, Turkey, (5) Başkent University Hospital Department Of Infectious Diseases And Clinical Microbiology, Turkey, (6) Ümraniye Training And Research Hospital Department Of Infectious Diseases And Clinical Microbiology, Turkey, (7) Ümraniye Training And Research Hospital Department Of Medical Microbiology, Turkey, (8) Kartal Koşuyolu Training And Research Hospital Department Of Infectious Diseases And Clinical Microbiology, Turkey, (9) Gaziantep University Hospital Department Of Infectious Diseases And Clinical Microbiology, Turkey, (10) Ankara University Hospital Department Of Infectious Diseases And Clinical Microbiology, Turkey, (11) Ankara University Hospital Department Of Medical Microbiology, Turkey, (12) Oxford University Department Of Biology, United Kingdom 2450P2099 WCK 4282 (cefepime/tazobactam, FEP/TAZ) : determination of tazobactam pharmacodynamic targets (PDTs) in presence of cefepime emplo- ying piperacillin/tazobactam-resistant ESBL or OXA-48-like-expressing Enterobacterales Anouk Muller17-04-202312:00 Poster Area PS036 Poster Session 5a. Mechanisms of action, new compounds, preclinical data & basic pharmacology of antibacteri- al agents (incl. investigational and non-traditional therapeutics) 12:00 Anouk Muller (1, 2, 3), Sanne Van Den Berg (2, 3), Kushal Umarkar (4), Pavan Tayde (4), Melroy Tellis (4), Ashwani Kumar (4), Rajesh Chavan (4), Vineet Zope (4), Swapna Takalkar (4), Hariharan Periasamy (4) - (1) Haaglanden Medisch Centrum, Netherlands, (2) Erasmus Mc, University Medical Center, Netherlands, (3) Center For Antimicrobial Optimized Treatment Rotterdam (Cator), Netherlands, (4) Wockhardt Research Center, IndiaFINAL PROGRAMME – 33RD ECCMID Copenhagen, Denmark 2023 21 CategorySub-categoryLink AbstractsLink EposterLink Oral Session 09. Experimental microbiology, micro- bial pathogenesis & biofilm 9a. Microbial pathogenesis & virulence https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13593&preview=1&aig=-1https://online.eccmid.org/programme-live-1?coday=2023-04-15&openSession=OS033 (Gshs), Turkey, (3) Infectious Diseases And Clinical Microbiology Department, Kartal Koşuyolu Training And Research Hospital, Turkey, (4) Koç University, College Of Engineering, Department Of Industrial Engineering, Turkey, (5) Koç University, School Of Medicine, 02. Bacterial infection & disease 2f. Community acquired nervous sys- tem and other multi-system bacterial infections (incl. epidemiology, clinical, imaging, treatment & prevention) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13594&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1435 02. Bacterial infection & disease 2b. Severe sepsis, bacteraemia & endocarditis (incl. epidemiology, diag- nosis, host bio-markers, treatment and outcome prediction) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13595&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1152 richs (1) - (1) Department Of Internal Medicine I, Infectious Diseases, University Hospital Schleswig-Holstein, Campus Kiel, Germany, (2) Department Of Internal Medicine Iii, Cardiology, University Hospital Schleswig-Holstein, Campus Kiel, Germany, (3) Department Schleswig-Holstein, Campus Kiel, Germany, (6) Hospital Pharmacy, University Hospital Schleswig-Holstein, Campus Kiel, Germany, (7) Department Of Nuclear Medicine And Molecular Imaging Diagnostics And Therapy, University Hospital Schleswig-Holstein, Campus 02. Bacterial infection & disease 2b. Severe sepsis, bacteraemia & endocarditis (incl. epidemiology, diag- nosis, host bio-markers, treatment and outcome prediction) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13596&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=E1234https://online.eccmid.org/programme-live-1?coday=2023-04-18&openSession=EF255 weden, (3) Department Of Microbiology, Karolinska University Hospital, Sweden 03. Bacterial suscepti- bility & resistance 3a. Resistance surveillance & epide- miology: MRSA, VRE & other Gram-po- sitives https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13597&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0042 02. Bacterial infection & disease 2g. Zoonotic bacterial infections (incl. foodborne, waterborne and vector-bor- ne pathogens, veterinary microbiology and One Health aspects, excl. AMR) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13598&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1462 ) Landeslabor Schleswig Holstein, Geschäftsbereich, Germany 11. Other 11d. Digital health and infection (incl. AI, data mining, informatics) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13599&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P3490 , United Kingdom, (3) Genomic Laboratory Hub (Glh), Addenbrooke’S Hospital, Cambridge University Hospitals Nhs Foundation Trust, United Kingdom, (4) Gastrointestinal Reference Services, Uk Health Security Agency, United Kingdom, (5) Institute For Risk Assess- 04. Diagnostic micro- biology 4e. Strain typing and surveillance (incl. molecular, genomic and other advan- ced methods) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13600&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1772 06. Fungal infection & disease 6b. Diagnostic mycology (incl. traditio- nal, molecular and other methods) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13603&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1991 12. COVID-19 12k. Other societal aspects (incl. econo- mics, mental health) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13604&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2765 03. Bacterial suscepti- bility & resistance 3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13606&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0555 , 3) - (1) Microbiology Unit, Reina Sofía University Hospital, Spain, (2) Maimonides Institute Of Biomedical Research Of Cordoba (Imibic), Spain, (3) Spanish Network For Research In Infectious Diseases (Reipi) And Ciber De Enfermedades Infecciosas (Ciberinfec), Insti- Inibic), Spain 03. Bacterial suscepti- bility & resistance 3c. Susceptibility testing methods (incl. assay validation, phenotypic assays and comparative studies, excl. TB) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13609&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0353 04. Diagnostic micro- biology 4c. MALTI-TOF and other proteomic methods https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13610&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=E0171https://online.eccmid.org/programme-live-1?coday=2023-04-15&openSession=EF035 f Pathology, Faculty Of Medicine, University Of Porto, Portugal, (2) Fastinov Sa, Portugal, (3) Cintesis-Center For Health Technology And Services Research, Faculty Of Medicine Of The University Of Porto, Portugal, (4) Servicio De Microbiología, Hospital Universitario 03. Bacterial suscepti- bility & resistance 3b. Resistance surveillance & epidemio- logy: Gram-negatives https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13611&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0227 , Ilkay Karaoğlan (9), Mehtap Aydin (6), Özlem Azap (5), Murat Kutlu (4), Refath Farzana (12), Timothy Walsh (12), Önder Ergönül (1, 2) - (1) Koç University Işbank Center For Infectious Diseases, Turkey, (2) Koç University Department Of Infectious Diseases And Clinical cal Microbiology, Turkey, (6) Ümraniye Training And Research Hospital Department Of Infectious Diseases And Clinical Microbiology, Turkey, (7) Ümraniye Training And Research Hospital Department Of Medical Microbiology, Turkey, (8) Kartal Koşuyolu Training And inical Microbiology, Turkey, (11) Ankara University Hospital Department Of Medical Microbiology, Turkey, (12) Oxford University Department Of Biology, United Kingdom 05. New antibacte- rial agents, PK/PD & Stewardship 5a. Mechanisms of action, new compounds, preclinical data & basic pharmacology of antibacterial agents (incl. investigational and non-traditional therapeutics) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13612&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2099 mus Mc, University Medical Center, Netherlands, (3) Center For Antimicrobial Optimized Treatment Rotterdam (Cator), Netherlands, (4) Wockhardt Research Center, IndiaABSTRACTS22 Abstracts Nr & Co-authors Presentation Nr TitlePresenterDateTime Inter- vention LocationSession Code Session TypeSessionSession Time 2451P0170 Comprehensive core genome multi-locus se- quence typing (MLST) and resistome analysis of carbapenemase-producing Klebsiella pneumoniae across the Arabian Peninsula Amani Alfadhli15-04-202312:00 Poster Area PS019 Poster Session 3b. Resistance surveillance and epidemiology: Gram-negatives 12:00 Amani Alfadhli (1), Shaimaa Mouftah (2), Akela Ghazawi (2), Wafaa Jamal (1), Vincent Rotimi (1) - (1) Kuwait University, Kuwait, (2) United Arab Emirates University, United Arab Emirates 2452P2119 APC247: a novel broad spectrum β-lactamase inhi- bitor demonstrating efficacy in vitro and in vivo Carina Matias17-04-202312:00 Poster Area PS036 Poster Session 5a. Mechanisms of action, new compounds, preclinical data & basic pharmacology of antibacteri- al agents (incl. investigational and non-traditional therapeutics) 12:00 Carina Matias (1), Åsmund Kaupang (2), Geir-Kildahl Andersen (3), Pål Rongved (4), Carina Vingsbo Lundberg (1), Jon Ulf Hansen (1) - (1) Statens Serum Institut, Denmark, (2) Dep. Of Pharmacy, The University Of Oslo, Norway, (3) Kappa Solutions As, Norway, (4) Adjutec Pharma As, Norway 2453O0632 Iron starvation induces functional type II toxin-an- titoxin modules in Waddlia chondrophila Gilbert Greub16-04-202315:33Hall POS131 1-hour Oral Session Anti-virulence targets at the bacterial surface 14:45 Silvia Ardissone, Gilbert Greub - (1) Institute Of Microbiology, Lausanne University Hospital And Lausanne University, Switzerland 2455P0011 Antimicrobial resistance, virulence and genetic lineages of Staphylococcus aureus implicated in skin and soft tissue infections of paediatric pati- ents: a five-year follow-up Allelen Cam- paña 15-04-202312:00 Poster Area PS018 Poster Session 3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives 12:00 Allelen Campaña (1), Carmen Lozano (1), Juan Manuel García-Lechuz (2), Ana Isabel López-Calleja (2), Irene Antoñanzas-Torres (3), Isabel Ferrer (4), Paula Eguizábal (1), Antonio Rezusta (2), Carmen Torres (1) - (1) Area Biochemistry And Molecular Biology, University Of La Rioja, Spain, (2) Service Of Microbiology, Hospital Miguel Servet, Spain, (3) Paediatrics, Hospital Universitario Miguel Servet, Spain, (4) Service Of Microbiology, Hospital Universitario Miguel Servet, Spain 2456P3320 Fusobacterium species: expanding clinical syndro- mes and diagnostics Ellen Sugrue18-04-202312:00 Poster Area PS095 Poster Session 13b. Bacterial infections12:00 Ellen Sugrue, Luke Tysall, Claire L. Mackintosh, Olga L. Moncayo-Nieto - (1) Nhs Lothian, United Kingdom 2457P1796 Prevalence of hypervirulent Klebsiella pneumoniae in a German university hospital Eyüp Doğan16-04-202312:00 Poster Area PS031 Poster Session 4f. Whole genome sequencing (incl. pathogen characterisation, diagnostics, excl. typing) 12:00 Eyüp Doğan (1), Elias Eger (2), Stefan E. Heiden (3), Karsten Becker (1), Katharina Schaufler (2, 3), Evgeny A. Idelevich (1, 4) - (1) Friedrich Loeffler-Institute Of Medical Microbiology, University Medicine Greifswald, Germany, (2) Institute Of Infection Medicine, Christian-Albrecht University Kiel And University Medical Center Schleswig-Holstein, Germany, (3) Pharmaceutical Microbiology, Institute Of Pharmacy, University Of Greifswald, Germany, (4) Institute Of Medical Microbiology, University Hospital Münster, Germany 2458P2691 COVIDRIVE: first public private partnership to conduct pan-European COVID-19 vaccine effecti- veness studies Kaatje Bollaerts17-04-202312:00 Poster Area PS088 Poster Session 12g. Vaccine development, trials, efficacy, policy 12:00 Kaatje Bollaerts (1), Antonio Carmona (2), Wilhelmine Meeraus (3), Claire Newbern (4), Vincent Bauchau (5), Laurence Torcel-Pagnon (6), Scott Chavers (7), Robert Tensen (8), Matthew Rousculp (9), Judith Pérez-Gómez (10), Suzanne Scheele (11), Hanna Nohynek (12) - (1) P95 Pharmacovigilance And Epidemiology, Belgium, (2) Fisabio Public Health, Spain, (3) Astrazeneca, United Kingdom, (4) Janssen, Belgium, (5) Vaccine Clinical Safety And Pharmacovigilance, Gsk, Belgium, (6) Vaccine Epidemiology And Modelling (Vem), Sanofi, France, (7) Moderna, United States, (8) Curevac, Germany, (9) Novavax, United States, (10) Valneva, France, (11) Bavarian Nordic, Denmark, (12) Finnish Institute For Health And Welfare, Finland 2459P0740 Efficacy of a silver-impregnated antimicrobial sho- werhead against healthcare waters contaminated with Pseudomonas aeruginosa Kush Karia15-04-202312:00 Poster Area PS059 Poster Session 8e. Hospital epidemiology, trans- mission, surveillance & screening (incl. environment) 12:00 Kush Karia, Shanom Ali - (1) University College London Hospitals Nhs Foundation Trust, United Kingdom 2460P0933 Optimising care for patients with suspected viral haemorrhagic fever: an evaluation of the patient care workflow and infection prevention procedu- res after the first 2 patients were admitted to a newly-built innovative high-level isolation unit Luca Zweers15-04-202312:00 Poster Area PS063 Poster Session 8i. Healthcare workers and infec- tion prevention (incl. vaccination, behavioural aspects, training and practices) 12:00 Luca Zweers (1), Manon Tingen-Wieland (1), Judith Hendriks (2), Edmée Bowles (1), Alma Tostmann (1), Chantal Bleeker-Rovers (2) - (1) Department Of Medical Microbiology, Radboud Centre For Infectious Diseases, Radboud University Medical Centre, Netherlands, (2) Department Of Internal Medicine, Radboud Centre For Infectious Diseases, Radboud University Medical Centre, Netherlands 2462P0133 Klebsiella pneumoniae: surveillance of antimicrobi- al resistance, clinical and molecular characteristics Fatihan Pınarlık15-04-202312:00 Poster Area PS019 Poster Session 3b. Resistance surveillance and epidemiology: Gram-negatives 12:00 Fatihan Pinarlik (1, 2), Lal Sude Gücer (1, 3, 2), Jale Boral (1, 2), Güz Ekinci (1, 2), Francis Cooper (1, 2), Nazlı Ataç (1), Irmak Çağlar (4), Aysun Benli (5), Nuran Sari (6), Merve Çağlar (7), Begüm Nalça Erdin (8), Ezgi Gülten (9), Şengül Üçer (10), Hande Afşarlar (11), Ayşe Özlem Mete (12), Özlem Şanli (13), Fatma Sena Hakyemez (14), Barçın Öztürk (15), Şiran Keske (16), Yeşim Besli (17), Lütfiye Öksüz (18), Uğur Ünal (19), Ülkü Tüzemen (19), Şirin Menekşe (20), Halis Akalin (19), Serap Şimşek Yavuz (5), Gökan Aygün (5), Yasemin Zer (21), Ilkay Karaoğlan (21), Ceren Karahan (22), Alpay Azap (9), Begüm Nalça Ergin (8), Mehtap Aydin (7), Özlem Azap (6), Ilknur Kaleli (23), Murat Kutlu (24), Mehmet Ali Öktem (25), Sema Alp Çavuş (4), Füsun Can (1, 26), Önder Ergönül (1, 3) - (1) Koç University Işbank Center For Infectious Diseases, Turkey, (2) Koç University Graduate School Of Health Sciences, Turkey, (3) Koç University Department Of Infectious Diseases And Clinical Microbiology, Turkey, (4) 9 Eylul University Department Of Infectious Diseases And Clinical Microbiology, Turkey, (5) Istanbul University Department Of Infectious Diseases And Clinical Microbiology, Turkey, (6) Baskent University Department Of Infectious Diseases And Clinical Microbiology, Turkey, (7) Ümraniye Research And Training Hospital Department Of Infectious Diseases And Clinical Microbiology, Turkey, (8) Ümraniye Research And Training Hospital Department Of Medical Microbiology, Turkey, (9) Ankara University Department Of Infectious Diseases And Clinical Microbiology, Turkey, (10) Hitit University Department Of Infectious Diseases And Clinical Microbiology, Turkey, (11) Hitit University Erol Olcok Research And Training Hospital Department Of Medical Microbiology, Turkey, (12) Gaziantep University Hospital Department Of Infectious Diseases And Clinical Microbiology, Turkey, (13) Başken University Hospital Department Of Medical Microbiology, Turkey, (14) Cerrahpaşa University Department Of Infectious Diseases And Clinical Microbiology, Turkey, (15) Adnan Menderes University Department Of Infectious Diseases And Clinical Microbiology, Turkey, (16) Americal Hospital Department Of Infectious Diseases And Clinical Microbiology, Turkey, (17) Americal Hospital Department Of Medical Microbiology, Turkey, (18) Istanbul University Department Of Medical Microbiology, Turkey, (19) Uludağ University Department Of Infectious Diseases And Clinical Microbiology, Turkey, (20) Kartal Koşuyolu Department Of Infectious Diseases And Clinical Microbiology, Turkey, (21) Gaziantep University Hospital Department Of Medical Microbiology, Turkey, (22) Ankara University Department Of Medical Microbiology, Turkey, (23) Pamukkale University Department Of Medical Microbiology, Turkey, (24) Pamukkale University Department Of Infectious Diseases And Clinical Microbiology, Turkey, (25) 9 Eylul University Department Of Medical Microbiology, Turkey, (26) Koç University Department Of Medical Microbiology, Turkey 2464P1607 National guideline for verification of real-time PCR analyses for ISO 15189 accreditation in the field of clinical microbiology Irene Harder Tarpgaard 16-04-202312:00 Poster Area PS027 Poster Session 4b. Laboratory management (incl. automation, data management, QC/QA, regulatory aspects) 12:00 Thomas Sundelin (1), Rikke Lind Jørgensen (2), Tina Vasehus Madsen (3), Irene Harder Tarpgaard (4), Silje Vermedal Høgh (5), Marianne Nielsine Skov (5) - (1) Department Of Clinical Microbiology, Herlev And Gentofte Hospital, Denmark, (2) Department Of Clinical Microbiology, Copenhagen University Hospital, Hvidovre Hospital, Denmark, (3) Department Of Clinical Microbiology, Zealand University Hospital, Koege, Denmark, (4) Department Of Clinical Microbiology, Aarhus University Hospital, Denmark, (5) Department Of Clinical Microbiology, Odense University Hospital, Denmark 2465O0057 Emergence of globally spread multi-drug resistant microorganisms from Ukrainian patients in the Netherlands Romy Zwittink15-04-20238:54Hall FOS012 2-hour Oral Session Special session: infectious diseases implications of the war in Ukraine 8:30 Romy Zwittink (1), Cornelia Wielders (1), Daan Notermans (1), Nelianne Verkaik (2), Annelot Schoffelen (1), Sandra Witteveen (1), Varisha Ganesh (1), Angela De Haan (1), Jeroen Bos (1), Jacinta Bakker (1), Caroline Schneeberger-Van Der LIndian (1), Ed Kuijper (1), Sabine De Greeff (1), Antoni Hendrickx (1) - (1) Center For Infectious Disease Control (Cib), National Institute For Public Health And The Environment (Rivm), Netherlands, (2) Swab Working Group Surveillance Of Antibiotic Resistance, Department Of Medical Micro biology And Infectious Diseases, Erasmus University Medical Center, Netherlands 2466E0589 Use of antifungals in acute hospital trusts in England, 2017-2021 Holly Fountain16-04-202313:30Arena 3EF121 1-hour ePoster Flash Session Fungal infection treatment around the world 13:30 Holly Fountain, Sabine Bou-Antoun, Berit Muller-Pebody, Colin S. Brown, Alicia Demirjian, Sarah M. Gerver - (1) Uk Health Security Agency, United Kingdom 2467E0471 Surgical antimicrobial prophylaxis in Japanese hospitals: current status and problems Hiroshi Mo- rioka 16-04-20239:54Arena 2EF089 1-hour ePoster Flash Session Antibiotic stewardship around the globe 9:30 Hiroshi Morioka, Tetsuya Yagi - (1) Department Of Infectious Diseases, Nagoya University Hospital, Japan 2468P2852 Molecular characterisationof human rhinovirus strains isolated from children with acute respirato- ry tract infections Ishani Bora17-04-202312:00 Poster Area PS003 Poster Session 1c. Influenza and respiratory viruses (incl. diagnostics & epide- miology, antiviral drugs, vaccines, treatment & susceptibility / resistance) 12:00 Ishani Bora (1), V R Parvathy (2), Pryanka Thakur (1), Vikram Thakur (1), Vikrant Sharma (1), Suresh Kumar Angurana (3), Mini P Singh (1), Radha Kanta Ratho (1) - (1) Virology,Pgimer, India, (2) Microbiology,Pgimer, India, (3) Pediatrics Pgimer, India 2469P0239 Antimicrobial resistance in Bacteroides spp. isola- tes in the health area of the University Virgen del Rocio Hospital in Seville, Spain Jose Luis Gar- cia-Escobar 15-04-202312:00 Poster Area PS019 Poster Session 3b. Resistance surveillance and epidemiology: Gram-negatives 12:00 Jose Luis Garcia-Escobar (1, 2), Lydia Galvez-Benitez (1, 2), Maria Jose Gomez-Gomez (1), Jose Antonio Lepe (1, 2, 3) - (1) Clinical Unit Of Infectious Diseases, Microbiology And Parasitology, University Hospital Virgen Del Rocío, Spain, (2) Institute Of Biomedicine Of Seville, University Of Seville/Csic/University Hospital Virgen Del Rocío, Spain, (3) Centro De Investigacion Biomedica En Red De Enfermedades Infecciosas (Ciberinfec), SpainFINAL PROGRAMME – 33RD ECCMID Copenhagen, Denmark 2023 23 CategorySub-categoryLink AbstractsLink EposterLink Oral Session 03. Bacterial suscepti- bility & resistance 3b. Resistance surveillance & epidemio- logy: Gram-negatives https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13613&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0170 05. New antibacte- rial agents, PK/PD & Stewardship 5a. Mechanisms of action, new compounds, preclinical data & basic pharmacology of antibacterial agents (incl. investigational and non-traditional therapeutics) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13614&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2119 jutec Pharma As, Norway 09. Experimental microbiology, micro- bial pathogenesis & biofilm 9d. Experimental and cellular micro- biology https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13615&preview=1&aig=-1https://online.eccmid.org/programme-live-1?coday=2023-04-16&openSession=OS131 03. Bacterial suscepti- bility & resistance 3a. Resistance surveillance & epide- miology: MRSA, VRE & other Gram-po- sitives https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13617&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0011 y Of La Rioja, Spain, (2) Service Of Microbiology, Hospital Miguel Servet, Spain, (3) Paediatrics, Hospital Universitario Miguel Servet, Spain, (4) Service Of Microbiology, Hospital Universitario Miguel Servet, Spain 13. Case reports and case series (n<10) 13b. Bacterial infections https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13618&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P3320 04. Diagnostic micro- biology 4f. Whole genome sequencing (incl. pathogen characterisation, diagnostics, excl. typing) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13619&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1796 tian-Albrecht University Kiel And University Medical Center Schleswig-Holstein, Germany, (3) Pharmaceutical Microbiology, Institute Of Pharmacy, University Of Greifswald, Germany, (4) Institute Of Medical Microbiology, University Hospital Münster, Germany 12. COVID-19 12g. Vaccine development, trials, efficacy, policy https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13620&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2691 12) - (1) P95 Pharmacovigilance And Epidemiology, Belgium, (2) Fisabio Public Health, Spain, (3) Astrazeneca, United Kingdom, (4) Janssen, Belgium, (5) Vaccine Clinical Safety And Pharmacovigilance, Gsk, Belgium, (6) Vaccine Epidemiology And Modelling (Vem), 08. Healthcare-as- sociated infections, infection prevention & control 8e. Hospital epidemiology, transmis- sion, surveillance & screening (incl. environment) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13621&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0740 08. Healthcare-as- sociated infections, infection prevention & control 8i. Healthcare workers and infection prevention (incl vaccination, behaviou- ral aspects, training and practices) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13622&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0933 s, (2) Department Of Internal Medicine, Radboud Centre For Infectious Diseases, Radboud University Medical Centre, Netherlands 03. Bacterial suscepti- bility & resistance 3b. Resistance surveillance & epidemio- logy: Gram-negatives https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13624&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0133 e Özlem Mete (12), Özlem Şanli (13), Fatma Sena Hakyemez (14), Barçın Öztürk (15), Şiran Keske (16), Yeşim Besli (17), Lütfiye Öksüz (18), Uğur Ünal (19), Ülkü Tüzemen (19), Şirin Menekşe (20), Halis Akalin (19), Serap Şimşek Yavuz (5), Gökan Aygün (5), Yasemin Zer nk Center For Infectious Diseases, Turkey, (2) Koç University Graduate School Of Health Sciences, Turkey, (3) Koç University Department Of Infectious Diseases And Clinical Microbiology, Turkey, (4) 9 Eylul University Department Of Infectious Diseases And Clinical Of Infectious Diseases And Clinical Microbiology, Turkey, (8) Ümraniye Research And Training Hospital Department Of Medical Microbiology, Turkey, (9) Ankara University Department Of Infectious Diseases And Clinical Microbiology, Turkey, (10) Hitit University robiology, Turkey, (13) Başken University Hospital Department Of Medical Microbiology, Turkey, (14) Cerrahpaşa University Department Of Infectious Diseases And Clinical Microbiology, Turkey, (15) Adnan Menderes University Department Of Infectious Diseases And ) Uludağ University Department Of Infectious Diseases And Clinical Microbiology, Turkey, (20) Kartal Koşuyolu Department Of Infectious Diseases And Clinical Microbiology, Turkey, (21) Gaziantep University Hospital Department Of Medical Microbiology, Turkey, (22) ent Of Medical Microbiology, Turkey, (26) Koç University Department Of Medical Microbiology, Turkey 04. Diagnostic micro- biology 4b. Laboratory management (incl. automation, data management, QC/ QA, regulatory aspects) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13626&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1607 Microbiology, Copenhagen University Hospital, Hvidovre Hospital, Denmark, (3) Department Of Clinical Microbiology, Zealand University Hospital, Koege, Denmark, (4) Department Of Clinical Microbiology, Aarhus University Hospital, Denmark, (5) Department Of 03. Bacterial suscepti- bility & resistance 3b. Resistance surveillance & epidemio- logy: Gram-negatives https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13627&preview=1&aig=-1https://online.eccmid.org/programme-live-1?coday=2023-04-15&openSession=OS012 abine De Greeff (1), Antoni Hendrickx (1) - (1) Center For Infectious Disease Control (Cib), National Institute For Public Health And The Environment (Rivm), Netherlands, (2) Swab Working Group Surveillance Of Antibiotic Resistance, Department Of Medical Micro- 06. Fungal infection & disease 6d. Antifungal drugs & treatment (incl. clinical trials) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13628&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=E0589https://online.eccmid.org/programme-live-1?coday=2023-04-16&openSession=EF121 05. New antibacte- rial agents, PK/PD & Stewardship 5d. Antimicrobial stewardship and pre- scribing (incl. interventions, monitoring, impact, decision-support / prediction tools, behavioural aspects) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13629&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=E0471https://online.eccmid.org/programme-live-1?coday=2023-04-16&openSession=EF089 01. Viral infection & disease (non CO- VID-19) 1c. Influenza and respiratory viruses (incl. diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13630&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2852 03. Bacterial suscepti- bility & resistance 3b. Resistance surveillance & epidemio- logy: Gram-negatives https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13631&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0239 Seville, University Of Seville/Csic/University Hospital Virgen Del Rocío, Spain, (3) Centro De Investigacion Biomedica En Red De Enfermedades Infecciosas (Ciberinfec), SpainABSTRACTS24 Abstracts Nr & Co-authors Presentation Nr TitlePresenterDateTime Inter- vention LocationSession Code Session TypeSessionSession Time 2470P1527 Comparing bacterial susceptibility protocols to TP- 102 phage cocktail: in diabetic foot infections from a phase I/IIa clinical trial and compassionate use Ron Braunstein16-04-202312:00 Poster Area PS026 Poster Session 4a. Diagnostic bacteriology (incl. culture based, traditional and general microbiology, serology) 12:00 Ron Braunstein (1), Ran Nir-Paz (2), Clara Leandro (3), Raquel Barbosa (3), Hadil Onallah (2), Yonatan Oster (2), Ronen Hazan (1) - (1) The Israeli Phage Therapy Center (Iptc), The Institute Of Biomedical And Oral Research (Ibor) In The Faculty Of Dental Medicine, The Hebrew University, Israel, (2) Department Of Clinical Microbiology And Infectious Diseases, Hadassah-Hebrew University Medical Center, Israel, (3) Technophage, Investigação E Desenvolvimento Em Biotecnologia S.A., Portugal 2471P0506 Move aside genomics: using proteomics for rapid sepsis diagnosis Tiphaine Cecchini 15-04-202312:00 Poster Area PS022 Poster Session 3e. Resistance detection / pre- diction approaches (rapid and/ or molecular assays, resistome analysis, inference methods) 12:00 Tiphaine Cecchini (1), Romain Carriere (2), Chloé Desbiolles (1), Roxane Prat (1), Lilya Wreyford (1), Francis Deforet (2), Maud Gregson (2), Pierre L‘Aour Dufour (1), Iulia Macavei (2), Eva Peyrache (2), Delphine Arquier (2), Gabriel Carvalho (2), Jean-Philippe Rasigade (1, 3), Olivier Dauwalder (1), Jerome Lemoine (2), François Vandenesch (1, 3) - (1) Hospices Civils De Lyon, Institut Des Agents Infectieux, France, (2) Institut Des Sciences Analytiques, Umr 5280, Cnrs, Université Claude Bernard Lyon 1, France, (3) Ciri, Centre Interna tional De Recherche En Infectiologie, Université De Lyon, Inserm U1111, Ecole Normale Supérieure De Lyon, Université Lyon 1, Cnrs, Umr5308, France 2472P1816 The interaction between vaginal microbiota and cervical length during pregnancy Gulı̇n Ozcan16-04-202312:00 Poster Area PS032 Poster Session 4g. Microbiome studies (incl. clinical and diagnostic studies, One Health aspects) 12:00 Gulı̇N Ozcan (1, 2), Cansel Vatansever (1), Erxiati Paerhati (3), Mert Turgal (4), Aykut Ozek (4), Tugba Gursoy (5), Attila Gürsoy (3), Özlem Keskin (3), Fusun Can (6, 1), Ebru Celik (4) - (1) Koç University Işbank Center For Infectious Diseases (Kuiscid), Turkey, (2) Koç University, Graduate School Of Health Sciences (Gshs), Turkey, (3) Koç University, College Of Engineering, Turkey, (4) Koc University, School Of Medicine, Department Of Obstetrics And Gynecology, Turkey, (5) Koc University, School Of Medicine, Department Of Pediatrics, Turkey, (6) Koc University, School Of Medicine, Department Of Medical Microbiology, Turkey 2473P2878 Prospective evaluation of T cell-mediated respon- se against Epstein-Barr virus in kidney transplant recipients Irene Cassaniti17-04-202312:00 Poster Area PS004 Poster Session 1d. Herpesviruses (incl. diagno- stics & epidemiology, antiviral drugs, treatment & susceptibility/ resistance, excl. clinical studies in immunocompromised hosts) 12:00 Federica Bergami (1), Irene Cassaniti (1), Daniele Lilleri (1), Giuditta Comolli (1), Francesca Arena (1), Marilena Gregorini (2), Teresa Rampino (2), Fausto Baldanti (1, 3) - (1) Microbiology And Virology Department, Fondazione Irccs Policlinico San Matteo, Italy, (2) Unit Of Nephrology, Dialysis, Transplantation, Fondazione Irccs Policlinico San Matteo, Italy, (3) Department Of Clinical, Surgical, Diagnostic And Pediatric Sciences, University Of Pavia, Italy 2477P1971 Evaluation of lateral flow device in bronchoalveo- lar lavage fluids for diagnosis of COVID-19-associa- ted pulmonary aspergillosis (CAPA) Juan Manuel Sánchez-Calvo 16-04-202312:00 Poster Area PS043 Poster Session 6b. Diagnostic mycology (incl. traditional, molecular and other methods) 12:00 Liliana Marcela Pesaresi (1), Clara González García (2), Isabel María Santiago Soler (1), Angel Estella García (3), María Dolores López Prieto (1), Juan Manuel Sánchez-Calvo (1) - (1) Hospital Universitario De Jerez. Unidad De Gestión Clínica De Enfermedades Infecciosas Y Microbiología, Spain, (2) Universidad De Cadiz. Facultad De Medicina, Spain, (3) Hospital Universitario De Jerez. Unidad De Gestión Clínica De Medicina Intensiva. Departamento De Medicina. Universidad De Cádiz. Inibica., Spain 2478P0359 Rapid antibiotic susceptibility testing of cultured Escherichia coli using a combination of high-reso- lution fluorescence microscopy, cellular phenoty- ping, and maChina learning Conor Feehily15-04-202312:00 Poster Area PS020 Poster Session 3c. Susceptibility testing methods (incl. assay validation, phenotypic assays and comparative studies, excl. TB) 12:00 Conor Feehily (1), Alexander Zagajewski (2, 3), Stelios Chatzimichail (2, 3), Piers Turner (2, 3), Alison Farrar (2, 3), Monique Andersson (1, 4), Lucinda Barrett (1, 4), Sarah Oakley (4), Derrick Crook (1, 4), Christoffer Nellåker (5), Achillefs N Kapanidis (2, 3), Nicole Stoesser (1, 4) - (1) Nuffield Department Of Medicine, University Of Oxford, United Kingdom, (2) Department Of Physics, University Of Oxford, United Kingdom, (3) Kavli Institute For Nanoscience Discovery, University Of Oxford, United Kingdom, (4) Department Of Microbiology And Infectious Diseases, Oxford University Hospitals Nhs Foundation Trust, United Kingdom, (5) Nuffield Department Of Women’S & Reproductive Health, University Of Oxford, Big Data Institute, United Kingdom 2480P2588 Evaluation of pooled testing approach for CO- VID-19 screening by real time RT-PCR Sibra Rahuma- th Mohamed Shihab 17-04-202312:00 Poster Area PS085 Poster Session 12d. Diagnostics (incl. molecular, genomic, rapid tests) 12:00 Mohammad Ihthisham Hameed Sulthan (1, 2), Ajith Prasanna Pitawela (2), Sibra Rahumath Mohamed Shihab (1), Bushran Noor Iqbal (3), Faseeha Noordeen (3) - (1) Postgraduate Institute Of Science, University Of Peradeniya, Sri Lanka, (2) Molecular Diagnostic Laboratory, Bandaranaike International Airport, Sri Lanka, (3) Department Of Microbiology, Faculty Of Medicine, University Of Peradeniya, Sri Lanka 2482O0063 Within-host and household genomic evolution of methicillin-resistant Staphylococcus aureus in long-term carriers Mette Damkjær Bartels 15-04-20238:42Hall LOS013 2-hour Oral Session All about whole genome sequen- cing in diagnostic microbiology 8:30 Tine Graakjær Larsen (1), Peder Worning (1), Jose Alfredo Samaniego Castruita (1), Henrik Westh (1, 2), Mette Damkjær Bartels (1, 2) - (1) Department Of Clinical Microbiology, Copenhagen University Hospital - Amager And Hvidovre, Denmark, (2) Department Of Clinical Medicine, University Of Copenhagen, Denmark 2483P0017 CA-MRSA and LA-MRSA: the story of food and clinic roaming clones Dalal Alkuraythi15-04-202312:00 Poster Area PS018 Poster Session 3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives 12:00 Dalal Alkuraythi (1, 2), Manal M. Alkhulaifi (3), Mohammed Alarawi (4), Abdulwahab Z. Binjomah (5, 6), Sulaiman M.I. Alajel (7), Takashi Gojobori (8) - (1) Department Of Botany And Microbiology, College Of Science, King Saud University, Saudi Arabia, (2) (Scbi) Biology Department, College Of Science, University Of Jeddah, Saudi Arabia, (3) Department Of Botany And Microbiology, College Of Science, King Saud University, Saudi Arabia, (4) Cbrc (Computational Bioscience Research Center), Bese (Biological And Environmental Sciences And Engineering), King Abdullah University Of Science And Technology, Saudi Arabia, (5) Microbiology Department, Riyadh Regional Laboratory, Ministry Of Health, Saudi Arabia, (6) College Of Medicine, Alfaisal University, Takhassusi Street., Saudi Arabia, (7) Reference Laboratory For Microbiology, Executive Department For Reference Laboratories, Research And Laboratories Sector, Saudi Food And Drug Authority, Saudi Arabia, (8) Distinguished Professor, Cbrc (Computational Bioscience Research Center), Bese (Biolo gical And Environmental Sciences And Engineering), Saudi Arabia 2486P0033 Reasons for hope? The epidemiology of resistant bacteria among Norwegian cancer patients 2008- 2018 Anders Skyrud Danielsen 15-04-202312:00 Poster Area PS018 Poster Session 3a. Resistance surveillance & epidemiology: MRSA, VRE & other Gram-positives 12:00 Anders Skyrud Danielsen (1, 2), Oliver Kacelnik (2), Jørgen Vildershøj Bjørnholt (2) - (1) Oslo University Hospital, Norway, (2) Norwegian Institute Of Public Health, Norway 2487P1910 Clonal spreading of fluconazole-resistant C. pa- rapsilosis causing invasive infections in patients admitted to a referral hospital located in Burgos, Northern Spain Jesus Guinea16-04-202312:00 Poster Area PS042 Poster Session 6a. Fungal disease epidemiology12:00 María De Los Ángeles Mantecón-Vallejo (1), Aina Mesquida (2), María Del Valle-Ortiz (1), Luis Buzón-Martín (1), Sergio Andrés Ossa Echeverri (1), Lourdes Fisac-Cuadrado (1), Gregoria Megías-Lobón (1), María Pilar Ortega-Lafont (1), Patricia Muñoz (2), Pilar Escribano (2), Jesus Guinea (2) - (1) Complejo Asistencial Universitario De Burgos, Spain, (2) Hospital Gregorio Marañón, Spain 2488E0459 Ethnic inequalities in COVID-19 infection, hospitali- sation, intensive care admission, and death: a glo- bal systematic review and meta-analysis informing the Priority Public Health Conditions Framework Patricia Irizar16-04-20238:30Arena 3EF088 1-hour ePoster Flash Session Around the world in 60 minutes with COVID 8:30 Patricia Irizar (1), Pan Daniel (2), Becares Laia (3), Kapadia Dharmi (1), Taylor Harry (1), Katikireddi Srinivasa Vittal (4), Wijekoon Kannangarage Niluka (5), Gomez Susana (5), Baggaley Rebecca (6), Nellums Laura (7), Swift Koller Theadora (5), Pareek Manish (6) - (1) University Of Manchester, United Kingdom, (2) University Hospitals Of Leicester Nhs Trust, United Kingdom, (3) King‘S College London, United Kingdom, (4) University Of Glasgow, United Kingdom, (5) World Health Organisation, Switzerland, (6) University Of Leices ter, United Kingdom, (7) University Of Nottingham, United Kingdom 2489P2190 Pharmacokinetics of BWC0977 in pulmonary epithelial lining fluid and efficacy in a neutropaenic lung infection model in rats Balasubrama- nian Venkata- raman 17-04-202312:00 Poster Area PS037 Poster Session 5b. Pharmacokinetics/pharma- codynamics of antibacterial drugs & therapeutic drug monitoring 12:00 Balasubramanian Venkataraman (1), Harish Kotakonda (1), Sambasiva Reddy (1), Ramesh Jayaraman (2), Mahesh Nanjundappa (2), Shahul Hameed (1) - (1) Bugworks Research India Pvt. Ltd., India, (2) Theraindx Pvt. Ltd., India 2490P1577 Direct rapid detection of extended-spec- trum-β-lactamase (ESBL) and metallo-β-lactamase (MBL) -producers in Enterobacterales from blood cultures Yuka Yamagishi16-04-202312:00 Poster Area PS026 Poster Session 4a. Diagnostic bacteriology (incl. culture based, traditional and general microbiology, serology) 12:00 Yuka Yamagishi (1), Norihisa Nakayama (2), Akito Doke (3), Saya Iwame (3), Yoshie Nishida (3), Shinji Tokuhiro (3), Akihito Yokoyama (4) - (1) Department Of Clinical Infectious Diseases, Kochi Medical School Hospital, Japan, (2) Fukoku Co., Ltd, Japan, (3) Division Of Clinical Laboratory, Department Of Medical Technology, Kochi Medical School Hospital, Japan, (4) Department Of Clinical Laboratory, Kochi Medical School Hospital, Japan 2492P1800 Characterisation of Burkholderia cenocepacia ST-250 isolates in patients with cystic fibrosis (CF) in Switzerland Andrea Zbinden16-04-202312:00 Poster Area PS031 Poster Session 4f. Whole genome sequencing (incl. pathogen characterisation, diagnostics, excl. typing) 12:00 Andrea ZbIndian (1), Helena Seth-Smith (1), Vanessa Beltrami (2), Stefano Mancini (2), Adrian Egli (2), Frank Imkamp (2) - (1) University Of Zurich, Instiute Of Medical Microbiology, Switzerland, (2) University Of Zurich, Institute Of Medical Microbiology, Switzerland 2494P1907 Multicentre epidemiological study ofYarrowia lipolyticain China from 2010 to 2020 Jin-Han Yu16-04-202312:00 Poster Area PS042 Poster Session 6a. Fungal disease epidemiology12:00 Jin-Han Yu - (1) Peking Union Medical College Hospital, ChinaFINAL PROGRAMME – 33RD ECCMID Copenhagen, Denmark 2023 25 CategorySub-categoryLink AbstractsLink EposterLink Oral Session 04. Diagnostic micro- biology 4a. Diagnostic bacteriology (incl. cul- ture based, traditional and general microbiology, serology) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13632&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1527 e Hebrew University, Israel, (2) Department Of Clinical Microbiology And Infectious Diseases, Hadassah-Hebrew University Medical Center, Israel, (3) Technophage, Investigação E Desenvolvimento Em Biotecnologia S.A., Portugal 03. Bacterial suscepti - bility & resistance 3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13633&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0506 (1, 3), Olivier Dauwalder (1), Jerome Lemoine (2), François Vandenesch (1, 3) - (1) Hospices Civils De Lyon, Institut Des Agents Infectieux, France, (2) Institut Des Sciences Analytiques, Umr 5280, Cnrs, Université Claude Bernard Lyon 1, France, (3) Ciri, Centre Interna- 04. Diagnostic micro- biology 4g. Microbiome studies (incl. clinical and diagnostic studies, One Health aspects) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13634&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1816 versity, Graduate School Of Health Sciences (Gshs), Turkey, (3) Koç University, College Of Engineering, Turkey, (4) Koc University, School Of Medicine, Department Of Obstetrics And Gynecology, Turkey, (5) Koc University, School Of Medicine, Department Of Pediatrics, 01. Viral infection & disease (non CO- VID-19) 1d. Herpesviruses (incl. diagnostics & epidemiology, antiviral drugs, treat- ment & susceptibility/resistance, excl clinical studies in immunocompromised hosts) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13635&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2878 it Of Nephrology, Dialysis, Transplantation, Fondazione Irccs Policlinico San Matteo, Italy, (3) Department Of Clinical, Surgical, Diagnostic And Pediatric Sciences, University Of Pavia, Italy 06. Fungal infection & disease 6b. Diagnostic mycology (incl. traditio- nal, molecular and other methods) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13639&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1971 sas Y Microbiología, Spain, (2) Universidad De Cadiz. Facultad De Medicina, Spain, (3) Hospital Universitario De Jerez. Unidad De Gestión Clínica De Medicina Intensiva. Departamento De Medicina. Universidad De Cádiz. Inibica., Spain 03. Bacterial suscepti- bility & resistance 3c. Susceptibility testing methods (incl. assay validation, phenotypic assays and comparative studies, excl. TB) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13640&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0359 ser (1, 4) - (1) Nuffield Department Of Medicine, University Of Oxford, United Kingdom, (2) Department Of Physics, University Of Oxford, United Kingdom, (3) Kavli Institute For Nanoscience Discovery, University Of Oxford, United Kingdom, (4) Department Of 12. COVID-19 12d. Diagnostics (incl. molecular, geno- mic, rapid tests) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13642&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2588 boratory, Bandaranaike International Airport, Sri Lanka, (3) Department Of Microbiology, Faculty Of Medicine, University Of Peradeniya, Sri Lanka 04. Diagnostic micro- biology 4f. Whole genome sequencing (incl. pathogen characterisation, diagnostics, excl. typing) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13644&preview=1&aig=-1https://online.eccmid.org/programme-live-1?coday=2023-04-15&openSession=OS013 linical Medicine, University Of Copenhagen, Denmark 03. Bacterial suscepti- bility & resistance 3a. Resistance surveillance & epide- miology: MRSA, VRE & other Gram-po- sitives https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13645&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0017 logy Department, College Of Science, University Of Jeddah, Saudi Arabia, (3) Department Of Botany And Microbiology, College Of Science, King Saud University, Saudi Arabia, (4) Cbrc (Computational Bioscience Research Center), Bese (Biological And Environmental 7) Reference Laboratory For Microbiology, Executive Department For Reference Laboratories, Research And Laboratories Sector, Saudi Food And Drug Authority, Saudi Arabia, (8) Distinguished Professor, Cbrc (Computational Bioscience Research Center), Bese (Biolo- 03. Bacterial suscepti- bility & resistance 3a. Resistance surveillance & epide- miology: MRSA, VRE & other Gram-po- sitives https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13648&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0033 06. Fungal infection & disease 6a. Fungal disease epidemiology https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13649&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1910 no (2), Jesus Guinea (2) - (1) Complejo Asistencial Universitario De Burgos, Spain, (2) Hospital Gregorio Marañón, Spain 12. COVID-19 12b. Epidemiology - local, regional, national, global https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13650&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=E0459https://online.eccmid.org/programme-live-1?coday=2023-04-16&openSession=EF088 niversity Of Manchester, United Kingdom, (2) University Hospitals Of Leicester Nhs Trust, United Kingdom, (3) King‘S College London, United Kingdom, (4) University Of Glasgow, United Kingdom, (5) World Health Organisation, Switzerland, (6) University Of Leices- 05. New antibacte- rial agents, PK/PD & Stewardship 5b. Pharmacokinetics/pharmacody- namics of antibacterial drugs & thera- peutic drug monitoring https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13651&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2190 04. Diagnostic micro- biology 4a. Diagnostic bacteriology (incl. cul- ture based, traditional and general microbiology, serology) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13652&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1577 Clinical Laboratory, Department Of Medical Technology, Kochi Medical School Hospital, Japan, (4) Department Of Clinical Laboratory, Kochi Medical School Hospital, Japan 04. Diagnostic micro- biology 4f. Whole genome sequencing (incl. pathogen characterisation, diagnostics, excl. typing) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13654&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1800 06. Fungal infection & disease 6a. Fungal disease epidemiology https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13656&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1907ABSTRACTS26 Abstracts Nr & Co-authors Presentation Nr TitlePresenterDateTime Inter- vention LocationSession Code Session TypeSessionSession Time 2495P2668 Vaccine specific antibodies in infants’ saliva breast- fed by women mRNA SARS-CoV-2 vaccinated Vicens Diaz-Bri- to Fernandez 17-04-202312:00 Poster Area PS087 Poster Session 12f. Immune response and modu- lation (incl. immunity and respon- se measurement, immunomodula- tion, antibody treatment) 12:00 Erika Esteve-Palau (1), Araceli Gonzalez-Cuevas (2), M. Eugenia Guerrero (2), Clara Garcia-Terol (3), Fran Medina (1), M Carmen Alvarez (1), Montserrat Sanmarti (1), Encarna Moreno (1), Sol Balsells (4), David Casadevall (5), Vicens Diaz-Brito Fernandez (1) - (1) Department Of Infectious Diseases, Parc Sanitari Sant Joan De Deu, Spain, (2) Department Of Microbiology, Parc Sanitari Sant Joan De Deu, Spain, (3) Department Of Obstetrics And Gynecology, Parc Sanitari Sant Joan De Deu, Spain, (4) Statistics Department, Sant Joan De Deu Research Foundation, Spain, (5) Cancer Research Program, Hospital Del Mar Research Institute, Spain 2496P0676 PhagoDAIR I: a pilot multi-centre, randomised, non-comparative, double-blind study of phage therapy in patients with hip or knee prosthetic joint infection due to Staphylococcus aureus trea- ted with DAIR and antibiotic Tristan Ferry15-04-202312:00 Poster Area PS056 Poster Session 8b. Other foreign-body and im- plant-associated infections (incl. PJI) 12:00 Tristan Ferry (1, 2), Eric Vicaut (3), Alex Soriano (3), Frederic Laurent (2), Alexandra Tizon (4), Pascal Birman (4), Eric Senneville (5) - (1) Service Des Maladies Infectieuses Et Tropicales, Hôpital De La Croix-Rousse, Hospices Civils De Lyon, France, (2) Centre Interrégional De Référence Pour La Prise En Charge Des Infections Ostéo-Articulaires Complexes (Crioac Lyon), France, (3) Unité De Recherche Clinique, Ghu-Nord Ap-Hp, Université Paris-Cité, France, (4) Pherecydes Pharma, France, (5) Department Of Infectious Diseases, Gustave Dron Hospital, Tourcoing, University Of Lille, France 2497P2092 Falciformispora senegalensisgrain model in Galle- ria mellonella larvae Ma Jingyi16-04-202312:00 Poster Area PS046 Poster Session 6e. Basic mycology (incl. in vitro and in vivo studies, pathogenesis) 12:00 Ma Jingyi (1), Mickey Konings (2), Annelies Verbon (3), Wendy Laureijssen-Van De Sande (4) - (1) Ma, Netherlands, (2) Konings, Netherlands, (3) Verbon, Netherlands, (4) Laureijssen-Van De Sande, Netherlands 2499O0037 Cloxacillin plus fosfomycin vs cloxacillin alone for methicillin-susceptible Staphylococcus aureus bacteraemia (SAFO) : a randomised clinical trial Sara Grillo15-04-20238:54Hall COS010 2-hour Oral Session Hot topics in sepsis8:30 Sara Grillo (1), Miquel Pujol Rojo (1, 2), Josep Maria Mirò Meda (3), Joaquín López-Contreras (4), Gorane Euba (5), Oriol Gasch (6), Lucia Boix-Palop (7), Maria José García-País (8), Maria Teresa Pérez-Rodríguez (9), Silvia Gomez-Zorrilla (10), Isabel Oriol-Bermudez (11), Luis Eduardo López-Cortés (12), Maria Luisa Pedro-Botet (13), Rafael San-Juan (14), Francesca Gioia (15), Simona Iftimie (16), Laura Morata (3), Alfredo Jover-Sáenz (17), Graciano Garcia-Pardo (18), Maria Belén Loeches-Yagüe (19), Yolanda Meije (20), Cristian Tebé (21), Jordi Carratalà (1, 2) - (1) Hospital Universitari Bellvitge, Spain, (2) Ciberinfect, Spain, (3) Hospital Clinic, Spain, (4) Hospital Santa Creu I Sant Pau, Spain, (5) Hospital Universitario Cruces, Spain, (6) Hospital Universitario Parc Taulí, Spain, (7) Hospital Universitari Mutua Terrassa, Spain, (8) Hospital Universitario Lucus Augusti, Spain, (9) Hospital Álvaro Cunqueiro, Spain, (10) Hospital Parc De Salut Mar, Spain, (11) Hospital Moisés Broggi, Spain, (12) Hospital Universitario Virgen Macarena, Spain, (13) Hospital Universitari Germans Trias I Pujol, Spain, (14) Hospital Universitario 12 De Octubre, Spain, (15) Hospital Universitario Ramón Y Cajal, Spain, (16) Hospital Universitari Sant Joan De Reus, Spain, (17) Hospital Universitari Arnau De Vilanova, Spain, (18) Hospital Universitari De Tarragona Joan Xxiii, Spain, (19) Hospital Universitario La Paz, Spain, (20) Hospital De Barcelona, Spain, (21) Institut De Investigació Biomédica De Bellvitge (Idibell, Spain 2500O0860 CoronaCheck: rapid development of a self-assess- ment and triage tool for managing the early stages of the COVID-19 pandemic in Switzerland Ludovico Cobuccio 17-04-202311:24Hall HOS176 1-hour Oral Session Digital applications for participato- ry infection surveillance 11:00 Ludovico Cobuccio, Alix Miauton, Maxime Hostettler, Florent Aeby, Julien Thabard, Valérie D‘Acremont - (1) Centre For Primary Care And Public Health (Unisanté), University Of Lausanne, Switzerland 2505P0110 Microbiological characterisation of Pseudomonas aeruginosa isolates recovered from cystic fibrosis patients: multicentre study, Spain Ainhize Maru- ri-Aransolo 15-04-202312:00 Poster Area PS019 Poster Session 3b. Resistance surveillance and epidemiology: Gram-negatives 12:00 Ainhize Maruri-Aransolo (1), Marta Hernández-García (1, 2), Carla Lopéz-Causape (3), Joan Figuerola (3), Casilda Olveira-Fuster (4), Rosa Girón (5), Carmen Luna (6), Antonio Oliver (3), Juan De Dios Caballero (1, 2), Rafael Cantón (1, 2) - (1) Hospital Universitario Ramón Y Cajal-Instituto Ramón Y Cajal De Investigación Sanitaria -Irycis, Spain, (2) Ciber De Enfermedades Infecciosas, (3) Hospital Son Espases, Instituto De Investigación Sanitaria Illes Balear-Idisba, Spain, (4) Hospital Regional Universitario De Málaga, Spain, (5) Hospi tal De La Princesa, Spain, (6) Hospital Universitario 12 De Octubre, Spain 2506E0229 What is the active ingredient in stool that prevents relapses in Clostridioides difficile infection? Luna Ballestero15-04-202313:48Arena 4EF049 1-hour ePoster Flash Session New insights in Clostridioides difficile: from pigs to poo 13:30 Luna Ballestero (1), Raquel Barbero-Herranz (1), Natalia Bastón-Paz (1), Mª Concepción Rodríguez-Jiménez (1), Blanca Viadel (2), Elena Diez (2), Sonia Porta (2), Patricia Del Rio (3), Celia Morales (3), Rosa Del Campo (1), José Avendaño-Ortiz (1) - (1) Hospital Ramón Y Cajal, Spain, (2) Ainia, Spain, (3) Mikrobomik, Spain 2507P0204 Complete genome sequence of a multidrug-re- sistant Pseudomonas aeruginosa ST773 causing local hospital outbreak in Czech Republic Katerina Chu- dejova 15-04-202312:00 Poster Area PS019 Poster Session 3b. Resistance surveillance and epidemiology: Gram-negatives 12:00 Katerina Chudejova (1, 2), Katerina Vlkova (1, 2), Jana Palkovicova (3), Ibrahim Bitar (1, 2), Jaroslav Hrabak (1, 2) - (1) Department Of Microbiology, Faculty Of Medicine, And University Hospital In Pilsen, Charles University, Czech Republic, (2) Biomedical Center, Faculty Of Medicine, Charles University, Czech Republic, (3) Central European Institute Of Technology, University Of Veterinary Sciences Brno, Czech Republic 2508O0265 Intra articular injection(s) of active bacteriopha- ges as adjuvant therapy in patients with prosthetic joint infections (PJI) qualified for open or arthros- copic “Debridement Antibiotics & Implant Retenti- on” (DAIR) followed by suppressive antimicrobial therapy (SAT) : the PHAGEinLYON experience at the CRIOAc Lyon referral centre Tristan Ferry15-04-202315:21Hall MOS060 1-hour Oral Session Epidemiology and management of prosthetic joint infections 14:45 Tristan Ferry (1, 2, 3), Thomas Briot (1), Camille Kolenda (1, 2, 3), Clément Javaux (1, 3), Gilles Leboucher (1), Fabien Craighero (1, 3), Sébastien Lustig (1, 3), Frederic Laurent (1, 2, 3), Cecile Batailler (1, 3) - (1) Hôpital De La Croix-Rousse, Hcl, France, (2) Centre International De Recherche En Infectiologie , France, (3) Centre Interrégional De Référence Pour La Prise En Charge Des Infections Ostéo-Articulaires Complexes (Crioac Lyon), Hospices Civils De Lyon, France 2510P2006 Azole resistance in Aspergillus fumigatus:data from the Czech surveillance study, 2019–2021 Pavlína Lysková16-04-202312:00 Poster Area PS044 Poster Session 6c. Antifungal susceptibility testing & resistance (incl. surveillance) 12:00 Pavlína Lysková (1), Kristýna Holíková (2), Daniela Lžičařová (3), Radim Dobiáš (4), Vít Hubka (2, 5) - (1) Department Of Medical Bacteriology Pak, National Reference Laboratory For Antifungals, Public Health Institute In Usti Nad Labem, Czech Republic, (2) Department Of Botany, Faculty Of Science, Charles University, Czech Republic, (3) Department Of Medical Microbiology, University Hospital In Motol, Czech Republic, (4) Department Of Bacteriology And Mycology, National Reference Laboratory For Mycological Diagnostics, Public Health Institute In Ostrava, Czech Republic, (5) Laboratory Of Fungal Genetics And Metabolism, Institute Of Microbiology Of The Czech Academy Of Sciences, Czech Republic 2512P1537 Prevalence and etiology of neonatal conjuncti- vitis: impact of a new microbiological diagnosis algorithm María So- ledad Zapi- co-González 16-04-202312:00 Poster Area PS026 Poster Session 4a. Diagnostic bacteriology (incl. culture based, traditional and general microbiology, serology) 12:00 Edurne Rodrigo-Arrazola, Martina Sánchez-Araujo, Laura Villa-Bajo, María Soledad Zapico-González - (1) Hospital Universitario Central De Asturias, Spain 2513O0777 Development of cefiderocol resistance during treatment in Klebsiella pneumoniae due to the association of fhuA, cirA and fiu mutations Luc Deroche17-04-20238:30Hall NOS158 2-hour Oral Session Last line antibiotics against pan- drug resistant Gram-negative bacteria 8:30 Luc Deroche (1, 2), François Arrivé (1), Jean-Philippe Martellosio (1), Sandrine Marchand (1, 2), Julien Buyck (2) - (1) Chu Poitiers, France, (2) Inserm U 1070 , France 2514P3116 Prevalence of infectious diseases and immunity to vaccine-preventable diseases among Ukrainian refugees in Germany: an analysis from the German Network University Medicine (NUM) Anette Fried- richs 17-04-202312:00 Poster Area PS051 Poster Session 7e. Travel medicine, migrant and refugee health 12:00 Anette Friedrichs (1), Folke Brinkmann (2, 3), Leonhard Hojenski (1), Yvonne Schmiedel (1), Anna Hoffmann (3), Christoph Maier (3), Franzi Trommel (4), Pia Behrens (4), Andreas Lindner (5), Sarah Holzwarth (6), Achim Kaasch (7), August Stich (8), Alexander Gussew (9), Daniel Heinrich (10), Marilyn Addo (11), Marie Freitag (12), Alexandra Dopfner-Jablonka (13), Lazar Mitrov (14), Margarete Scherer (14), Claudia Denkinger (15), Gunnar Brandhorst (16), Astrid Petersmann (16), Maria Vehreschild (4) - (1) Department Of Internal Medicine I, Infectious Diseases, University Hospital Schleswig-Holstein, Campus Kiel, Germany, (2) Department Of Pediatrics, University Hospital Schleswig-Holstein, Campus Lübeck, Germany, (3) Department Of Pediatrics, Ruhr-University Of Bochum, Germany, (4) Department Of Internal Medicine Ii, Hematology/Oncology, Goethe University Frankfurt, Germany, (5) Institute Of Tropical Medicine And International Health, Charité, Germany, (6) Department Of Pediatrics, University Hospital Carl Gustav Carus, Germany, (7) Institute Of Medical Microbiology And Infection Control, Otto-Von-Guericke University, Germany, (8) Department Of Tropical Medicine, Missio Hospital, Germany, (9) Department Of Radiology, University Hospital Halle, Germany, (10) Department Of Internal Medicine Iv, Ludwigs-Maximilian-University München, Germany, (11) Division Of Infectious Diseases, Department Of Medicine I, University Hospital Eppendorf, Germany, (12) University Hospital Augsburg, Germany, (13) Department Of Rheumatology And Immunology, Hannover Medical School, Germany, (14) Department Of Internal Medicine I, University Hospital Cologne, Germany, (15) Division Of Infectious Diseases And Tropical Medicine, University Hospital Heidelberg, Germany, (16) Institute For Clinical Chemistry And Laboratory Medicine, Oldenburg Hospital, Germany 2515E0450 Source attribution of Staphylococcus aureus through a polyphasic approach based on whole genome sequence data Beatriz Ramos16-04-20238:30Arena 1EF087 1-hour ePoster Flash Session MRSA: still an important pathogen8:30 Beatriz Ramos (1, 2), Josman D. Palmeira (3), Rita T. Torres (3), Mónica V. Cunha (1, 2) - (1) Centre For Ecology, Evolution And Environmental Changes (Ce3C) & Change - Global Change And Sustainability Institute, Faculdade De Ciências Da Universidade De Lisboa, Portugal, (2) Biosystems And Integrative Sciences Institute (Bioisi), Faculdade De Ciências Da Universidade De Lisboa, Portugal, (3) Cesam - Centre For Environmental And Marine Studies, Department Of Biology, University Of Aveiro, Portugal 2516O0414 Overview of safety and immunogenicity of an Ad26.ZEBOV booster dose given up to 4.5 years after Ad26.ZEBOV, MVA-BN-Filo primary regimen in phase 2 and 3 trials conducted in various popu- lations in Africa Chelsea Mclean16-04-20239:18Hall COS083 2-hour Oral Session New vaccines in clinical develop- ment 8:30 Chelsea Mclean (1), Auguste Gaddah (2), Bailah Leigh (3), Ggayi Abu-Baker Mustapher (4), Omu Anzala (5), Babajide Keshinro (6), Michael Katwere (6), Valerie Oriol-Mathieu (6), Rodolphe Thiebaut (7), Daniela Manno (8), Edward Choi (8), Pontiano Kaleebu (4), Brian Greenwood (8), Deborah Watson-Jones (8), Kerstin Luhn (1), Cynthia Robinson (1), Macaya Douoguih (1) - (1) Janssen Vaccines And Prevention Bv, Netherlands, (2) Janssen Research And Development, Belgium, (3) College Of Medicine And Allied Health Sciences, University Of Sierra Leone, Sierra Leone, (4) Mrc/Uvri And Lshtm Uganda Research Unit, Uganda, (5) Kavi - Institute Of Clinical Research, Kenya, (6) Anssen Vaccines And Prevention Bv, Netherlands, (7) University Of Bordeaux, Inserm, France, (8) London School Of Hygiene & Tropical Medicine, United KingdomFINAL PROGRAMME – 33RD ECCMID Copenhagen, Denmark 2023 27 CategorySub-categoryLink AbstractsLink EposterLink Oral Session 12. COVID-19 12f. Immune response and modulation (incl. immunity and response measu- rement, immunomodulation, antibody treatment) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13657&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2668 artment Of Infectious Diseases, Parc Sanitari Sant Joan De Deu, Spain, (2) Department Of Microbiology, Parc Sanitari Sant Joan De Deu, Spain, (3) Department Of Obstetrics And Gynecology, Parc Sanitari Sant Joan De Deu, Spain, (4) Statistics Department, Sant Joan 08. Healthcare-as- sociated infections, infection prevention & control 8b. Other foreign-body and implant-as- sociated infections (incl. PJI) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13658&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0676 nal De Référence Pour La Prise En Charge Des Infections Ostéo-Articulaires Complexes (Crioac Lyon), France, (3) Unité De Recherche Clinique, Ghu-Nord Ap-Hp, Université Paris-Cité, France, (4) Pherecydes Pharma, France, (5) Department Of Infectious Diseases, 06. Fungal infection & disease 6e. Basic mycology (incl. in vitro and in vivo studies, pathogenesis) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13659&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2092 02. Bacterial infection & disease 2b. Severe sepsis, bacteraemia & endocarditis (incl. epidemiology, diag- nosis, host bio-markers, treatment and outcome prediction) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13661&preview=1&aig=-1https://online.eccmid.org/programme-live-1?coday=2023-04-15&openSession=OS010 1), Luis Eduardo López-Cortés (12), Maria Luisa Pedro-Botet (13), Rafael San-Juan (14), Francesca Gioia (15), Simona Iftimie (16), Laura Morata (3), Alfredo Jover-Sáenz (17), Graciano Garcia-Pardo (18), Maria Belén Loeches-Yagüe (19), Yolanda Meije (20), Cristian sitari Mutua Terrassa, Spain, (8) Hospital Universitario Lucus Augusti, Spain, (9) Hospital Álvaro Cunqueiro, Spain, (10) Hospital Parc De Salut Mar, Spain, (11) Hospital Moisés Broggi, Spain, (12) Hospital Universitario Virgen Macarena, Spain, (13) Hospital Universitari agona Joan Xxiii, Spain, (19) Hospital Universitario La Paz, Spain, (20) Hospital De Barcelona, Spain, (21) Institut De Investigació Biomédica De Bellvitge (Idibell, Spain 11. Other 11d. Digital health and infection (incl. AI, data mining, informatics) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13662&preview=1&aig=-1https://online.eccmid.org/programme-live-1?coday=2023-04-17&openSession=OS176 03. Bacterial suscepti- bility & resistance 3b. Resistance surveillance & epidemio- logy: Gram-negatives https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13667&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0110 món Y Cajal-Instituto Ramón Y Cajal De Investigación Sanitaria -Irycis, Spain, (2) Ciber De Enfermedades Infecciosas, (3) Hospital Son Espases, Instituto De Investigación Sanitaria Illes Balear-Idisba, Spain, (4) Hospital Regional Universitario De Málaga, Spain, (5) Hospi- 08. Healthcare-as- sociated infections, infection prevention & control 8g. Infection control interventions and trials (incl. microbiota transplantation) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13668&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=E0229https://online.eccmid.org/programme-live-1?coday=2023-04-15&openSession=EF049 Y Cajal, Spain, (2) Ainia, Spain, (3) Mikrobomik, Spain 03. Bacterial suscepti- bility & resistance 3b. Resistance surveillance & epidemio- logy: Gram-negatives https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13669&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0204 ulty Of Medicine, Charles University, Czech Republic, (3) Central European Institute Of Technology, University Of Veterinary Sciences Brno, Czech Republic 08. Healthcare-as- sociated infections, infection prevention & control 8b. Other foreign-body and implant-as- sociated infections (incl. PJI) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13670&preview=1&aig=-1https://online.eccmid.org/programme-live-1?coday=2023-04-15&openSession=OS060 national De Recherche En Infectiologie , France, (3) Centre Interrégional De Référence Pour La Prise En Charge Des Infections Ostéo-Articulaires Complexes (Crioac Lyon), Hospices Civils De Lyon, France 06. Fungal infection & disease 6c. Antifungal susceptibility testing & resistance (incl. surveillance) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13672&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2006 ent Of Botany, Faculty Of Science, Charles University, Czech Republic, (3) Department Of Medical Microbiology, University Hospital In Motol, Czech Republic, (4) Department Of Bacteriology And Mycology, National Reference Laboratory For Mycological Diagnostics, 04. Diagnostic micro- biology 4a. Diagnostic bacteriology (incl. cul- ture based, traditional and general microbiology, serology) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13674&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1537 03. Bacterial suscepti- bility & resistance 3d. Resistance mechanisms incl. in vitro and in vivo studies, mobile elements (excl. TB) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13675&preview=1&aig=-1https://online.eccmid.org/programme-live-1?coday=2023-04-17&openSession=OS158 07. Parasitic diseases & global health 7e. Travel medicine, migrant and refugee health https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13676&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P3116 (9), Daniel Heinrich (10), Marilyn Addo (11), Marie Freitag (12), Alexandra Dopfner-Jablonka (13), Lazar Mitrov (14), Margarete Scherer (14), Claudia Denkinger (15), Gunnar Brandhorst (16), Astrid Petersmann (16), Maria Vehreschild (4) - (1) Department Of Internal Department Of Internal Medicine Ii, Hematology/Oncology, Goethe University Frankfurt, Germany, (5) Institute Of Tropical Medicine And International Health, Charité, Germany, (6) Department Of Pediatrics, University Hospital Carl Gustav Carus, Germany, (7) ne Iv, Ludwigs-Maximilian-University München, Germany, (11) Division Of Infectious Diseases, Department Of Medicine I, University Hospital Eppendorf, Germany, (12) University Hospital Augsburg, Germany, (13) Department Of Rheumatology And Immunology, atory Medicine, Oldenburg Hospital, Germany 03. Bacterial suscepti- bility & resistance 3g. Spread of resistance incl. carriage, reservoirs, ecology, models (excl. noso- comial transmission) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13677&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=E0450https://online.eccmid.org/programme-live-1?coday=2023-04-16&openSession=EF087 ortugal, (2) Biosystems And Integrative Sciences Institute (Bioisi), Faculdade De Ciências Da Universidade De Lisboa, Portugal, (3) Cesam - Centre For Environmental And Marine Studies, Department Of Biology, University Of Aveiro, Portugal 10. Immunology, Immune compromise & vaccinology 10d. Antiviral vaccines (excl. influenza, respiratory and bloodborne viruses and COVID-19) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13678&preview=1&aig=-1https://online.eccmid.org/programme-live-1?coday=2023-04-16&openSession=OS083 n Greenwood (8), Deborah Watson-Jones (8), Kerstin Luhn (1), Cynthia Robinson (1), Macaya Douoguih (1) - (1) Janssen Vaccines And Prevention Bv, Netherlands, (2) Janssen Research And Development, Belgium, (3) College Of Medicine And Allied Health Sciences, ygiene & Tropical Medicine, United KingdomABSTRACTS28 Abstracts Nr & Co-authors Presentation Nr TitlePresenterDateTime Inter- vention LocationSession Code Session TypeSessionSession Time 2518P2735 Barrier-free COVID-19 screening for healthcare workers: an initiative from Irish hospital Benson Jacob17-04-202312:00 Poster Area PS089 Poster Session 12h. Infection prevention and control (incl. healthcare facilities, community, schools) 12:00 Benson Jacob, Rozanna Hardie, Aoife Ni Dhuthaigh, Eoghan De Barra - (1) Beaumont Hospital, Ireland 2519E0642 A retrospective study on impact of antibiotic the- rapy on mortality in viral respiratory infections Magrit Jarlsdat- ter Hovind 16-04-202314:45Arena 4EF133 1-hour ePoster Flash Session Seasonal respiratory virus: a conti- nued challenge 14:45 Magrit Jarlsdatter Hovind, Jan Erik Berdal, Olav Dalgard, Magnus Nakrem Lyngbakken - (1) Department Of Infectious Diseases, Akershus University Hospital, Lørenskog, Norway. 2. Institute For Clinical Medicine, University Of Oslo, Norway 2520E0476 Strongyloides stercoralis diagnosis during CO- VID-19 pandemic in an urban teaching hospital in Spain Isabel Fradejas16-04-20239:30Arena 4EF090 1-hour ePoster Flash Session Intestinal pathogens: old prob- lems, new challenges 9:30 Isabel Fradejas, Diego Gayoso, Adriana María Ortega, Carolina Campelo, Martin Carlos Grados, Jose Francisco Valverde, Maria Jose Goyanes, Maria Velasco - (1) Hospital Universitario Fundación Alcorcón, Spain 2521P2102 Efficacy of RG6006 in murine models of infections, including sepsis, thigh and lung induced by Acine- tobacter Livia Ferrari17-04-202312:00 Poster Area PS036 Poster Session 5a. Mechanisms of action, new compounds, preclinical data & basic pharmacology of antibacteri- al agents (incl. investigational and non-traditional therapeutics) 12:00 Paola Savoia (1), Livia Ferrari (1), Caterina Bissantz (2), William Riboulet (2), Lotte Winther (2), Antonio Felici (1), Claudia Zampaloni (2) - (1) Aptuit Verona Srl, An Evotec Company, Italy, (2) F. Hoffmann-La Roche Ltd, Switzerland 2523O1123 Adoptive cell therapy with memory T lymphocytes to treat infectious diseases Karima Al-Aki- oui Sanz 18-04-202310:06Hall JOS231 2-hour Oral Session Novel strategies for anti-COVID treatment: still a challenge 8:30 Karima Al-Akioui Sanz (1), Cristina Ferreras (1), Alejandro Martín-Quirós (2), Marta Menéndez-Ribes (1), Alfonso Navarro-Zapata (1), Carmen Mestre-Durán (1), Laura Clares-Villa (1), Jordi Minguillón-Pedreno (1), Carlos Echecopar-Parente (3), José Luis Vicario (4), Antonio Balas (4), Raquel De Paz (5), Mercedes Gasior (6), Eduardo López-Granados (7), Carlos Jiménez (8), Ester Ramos (9), Francisco Hernández-Oliveros (10), Clara Hernández-Blanco (11), Antonio Pérez-Martínez (1, 3, 12) - (1) University Hospital La Paz Research In stitute (Idipaz), Spain, (2) Emergency Unit, Internal Medicine Department, University Hospital La Paz, Spain, (3) Pediatric Hemato-Oncology, University Hospital La Paz, Spain, (4) Histocompatibility Unit, Centro De Transfusión Comunidad De Madrid, Spain, (5) Cell Therapy Unit, Hematology Department, La Paz University Hospital, Spain, (6) Hematology Department, University Hospital La Paz, Spain, (7) Immunology Unit, University Hospital La Paz, Spain, (8) Nephrology Department, University Hospital La Paz, Spain, (9) Pediatric Gastroenterology And Nutrition Unit, University Hospital La Paz, Spain, (10) Pediatric Surgery Department, University Hospital La Paz, Spain, (11) Internal Medicine Department, Enfermera Isabel Zendal Hospital, Spain, (12) Pediatric Department, Universidad Autónoma De Madrid, Spain 2524P0777 Escherichia coli in paediatric patients at a tertiary hospital Frederik Boeti- us Hertz 15-04-202312:00 Poster Area PS059 Poster Session 8e. Hospital epidemiology, trans- mission, surveillance & screening (incl. environment) 12:00 Frederik Boetius Hertz (1), Karen Leth Nielsen (1), Rasmus Lykke Marvig (1), Steen Christian Rasmussen (1), Sonja Lekovic (1), Maria Louise Braarup Desauv (1), Susanne Haussler (1, 2) - (1) Rigshospitalet, Denmark, (2) Twincore, Germany 2525O0064 Utilising large and diverse bacterial genome data- sets to improve the identification of Streptococcus pneumoniae via PCR-based diagnostics Femke Ahlers15-04-20238:54Hall LOS013 2-hour Oral Session All about whole genome sequen- cing in diagnostic microbiology 8:30 Femke Ahlers (1), David Litt (2), Melissa Jansen Van Rensburg (1), James Bray (3), Keith Jolley (3), Seyi Eletu (2), Juliana Coelho (4), Bruno Pichon (5), Odile Harrison (3), Martin Maiden (3), David Eyre (1), Norman Fry (2, 6), Angela Brueggemann (1) - (1) Nuffield Department Of Population Health, University Of Oxford, United Kingdom, (2) Respiratory And Vaccine Preventable Bacteria Reference Unit, Uk Health Security Agency, United Kingdom, (3) Department Of Biology, University Of Oxford, United Kingdom, (4) Antimicrobial Resistance And Healthcare Associated Infection Unit, Uk Health Security Agency, United Kingdom, (5) Healthcare Associated Infections, Fungal, Amr, Amu & Sepsis Division, Uk Health Security Agency, United Kingdom, (6) Immunisation And Vaccine Preventable Diseases, Uk Health Security Agency, United Kingdom 2526P0379 Evaluation of an ATP bioluminescence assay in time-kill curves for the study of antibiotic comibi- nations against Klebsiella pneumoniae as an alter- native to the conventional colony count method Núria Prim15-04-202312:00 Poster Area PS020 Poster Session 3c. Susceptibility testing methods (incl. assay validation, phenotypic assays and comparative studies, excl. TB) 12:00 Berta Puig-Collderram (1), Natalia Garcia-Caballero (1), Natalia Mingorance-Garcia (1), Alba Crespo-Carrasco (1), Sandra Domene-Ochoa (2), Maria Milagro Montero (2), Xavier Duran (3), Juan R González (4, 5, 6), Santiago Grau (7), Juan P Horcajada (2), Eduardo Padilla (1), Concepción Segura (1), Núria Prim (1) - (1) Laboratori De Referència De Catalunya, Spain, (2) Hospital Del Mar, Spain, (3) Institut Del Mar D‘Investigacions Mèdiques, Spain, (4) Institute For Global Health Isglobal, Spain, (5) Universitat Pompeu Fabra (Upf), Spain, (6) Ciber Epidemiología Y Salyd Pública (Ciberesp), Spain, (7) Pharmacy Service, Hospital Del Mar, Spain 2527O0917 Role of pericytes in experimental pneumococcal meningitis: investigations in a mouse model Nina Carina Teske 17-04-202313:42Hall COS191 1-hour Oral Session New developments in bacterial CNS infections 13:30 Nina Carina Teske (1), Barbara Angele (1), Roland Kälin (2), Sven Hammerschmidt (3), Matthias Klein (1), Hans-Walter Pfister (1), Rainer Glaß (2), Uwe Ködel (1) - (1) Laboratory Of Neuroinfectious Diseases, Department Of Neurology, Klinikum Großhadern, Ludwig-Maximilians University, Germany, (2) Neurosurgical Research, Department Of Neurosurgery, Klinikum Großhadern, Ludwig nal Genomics, Center For Functional Genomics Of Microbes, University Of Greifswald, Germany 2529P0114 High rate of carbapenem resistant Klebsiella pneu- moniae in wastewater from Belgium Hanne Debergh15-04-202312:00 Poster Area PS019 Poster Session 3b. Resistance surveillance and epidemiology: Gram-negatives 12:00 Hanne Debergh (1, 2, 3), Cristina Garcia-Graells (1), Cécile Boland (2), Claude Saegerman (3), Koenraad Van Hoorde (1) - (1) Service Foodborne Pathogens, Sciensano, Belgium, (2) Veterinary Bacteriology Service, Sciensano, Belgium, (3) Research Unit In Epidemiology And Risk Analysis Applied To Veterinary Sciences (Urear-Uliège), Fundamental And Applied Research For Animal And Health (Farah) Center, University Of Liège, Belgium 2530P3331 Postoperative wound infection after lung trans- plantation caused by Metamycoplasma hominis detected from anaerobic cultures Jakub Kantor18-04-202312:00 Poster Area PS095 Poster Session 13b. Bacterial infections12:00 Jakub Kantor (1), Jakub Hurych (1), Markéta Vaculová (2), Milena Antušková (1), Daniela Lžičařová (1), Vanda Chrenková (1), Pavel Dřevínek (1), Oto Melter (1) - (1) Departmend Of Medical Microbiology, 2Nd Faculty Of Medicine, Charles University And Motol University Hospital, Czech Republic, (2) Iii. Department Of Surgery, 1St Medical Faculty, Charles University And University Hospital Motol, Czech Republic 2531P0493 Proteomic analysis of multidrug-resistant and -susceptible strains of Escherichia coli to discern novel drug targts Neelja Singhal15-04-202312:00 Poster Area PS022 Poster Session 3e. Resistance detection / pre- diction approaches (rapid and/ or molecular assays, resistome analysis, inference methods) 12:00 Neelja Singhal - (1) University Of Delhi South Campus, India 2532P0958 Relating bacterial characteristics in Staphylococcus aureus bacteremia to clinical manifestations and outcome: a retrospective cohort study Marianne Hendriks 15-04-202312:00 Poster Area PS064 Poster Session 9a. Microbial pathogenesis and virulence 12:00 Marianne Hendriks, Ingrid Van Weerdenburg, Jordy Coolen, Ilse Kouijzer, Jaap Ten Oever, Heiman Wertheim - (1) Radboudumc Center For Infectious Diseases, Netherlands 2533P1686 Diagnostic value of amplification and sequencing of the 16S rRNA gene for pathogen identification in culture-negative clinical samples Florence Doucet-Popu- laire 16-04-202312:00 Poster Area PS029 Poster Session 4d. Molecular diagnostics (incl. POCT and syndromic testing) 12:00 Nadège Bourgeois-Nicolaos (1, 2), Kevin Boumeghar (1), Wafa Ben Nejma (1), Christelle Guillet-Caruba (1), Dorothée Vignes (1), Benoit Villain (1), Thierry Bégué (1), Florence Doucet-Populaire (1, 2) - (1) Aphp Université Paris-Saclay, France, (2) I2Bc, France 2534P1440 Spatial analysis of unfavorable outcomes associ- ated with congenital syphilis as a tool for health policy planning Carlos Kiffer16-04-202312:00 Poster Area PS015 Poster Session 2f. Community acquired nervous system and other multi-system bacterial infections(incl. epide- miology, clinical, imaging, treat- ment & prevention) 12:00 Daniela Costa-Nobre (1), Angela Tayra (2), Carmen Domingues (2), Marli Prado (2), Adriana Sanudo (1), Rita Balda (1), Larissa Festa (3), Amanda Jesuino (3), Mariana Schveitzer (1), Mariza Tancredi (2), Carla Luppi Cg (1), Carlos Kiffer (1) - (1) Epm Unifesp, Brazil, (2) Ses, Crt, Dst/Aids, Brazil, (3) Usp, Brazil 2536P1166 Evaluation of the impact of a fast diagnostic path in a northern Italian hospital: comparison between two cohorts of patients with severe sepsis Sara Grasselli16-04-202312:00 Poster Area PS011 Poster Session 2b. Severe sepsis, bacteraemia & endocarditis (incl. epidemiology, diagnosis, host bio-markers, treat- ment and outcome prediction) 12:00 Sara Grasselli (1), Andrea Zappavigna (2), Chiara Colarossi (3), Valeriia Dambina (3), Giorgio Economopoulous (3), Federica Tesei (3), Lorena La Vergata (2), Chiara Gorrini (2), Valentina Lepera (2), Domenico Caleca (2), Paolo Gigante (2), Gabriella Tocci (2), Roberta Schiavo (2), Mauro Codeluppi (1), Giuliana Lo Cascio (2) - (1) Hospital Of Piacenza, Infectious Diseases Unit, Italy, (2) Hospital Of Piacenza, Microbiology Unit, Italy, (3) University Of Parma, ItalyFINAL PROGRAMME – 33RD ECCMID Copenhagen, Denmark 2023 29 CategorySub-categoryLink AbstractsLink EposterLink Oral Session 12. COVID-19 12h. Infection prevention and control (incl. healthcare facilities, community, schools) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13680&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2735 01. Viral infection & disease (non CO- VID-19) 1c. Influenza and respiratory viruses (incl. diagnostics & epidemiology, antiviral drugs, vaccines, treatment & susceptibility / resistance) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13681&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=E0642https://online.eccmid.org/programme-live-1?coday=2023-04-16&openSession=EF133 07. Parasitic diseases & global health 7b. Diagnostic parasitology (incl. traditi- onal, molecular and other methods) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13682&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=E0476https://online.eccmid.org/programme-live-1?coday=2023-04-16&openSession=EF090 05. New antibacte- rial agents, PK/PD & Stewardship 5a. Mechanisms of action, new compounds, preclinical data & basic pharmacology of antibacterial agents (incl. investigational and non-traditional therapeutics) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13683&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P2102 12. COVID-19 12f. Immune response and modulation (incl. immunity and response measu- rement, immunomodulation, antibody treatment) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13685&preview=1&aig=-1https://online.eccmid.org/programme-live-1?coday=2023-04-18&openSession=OS231 ntonio Balas (4), Raquel De Paz (5), Mercedes Gasior (6), Eduardo López-Granados (7), Carlos Jiménez (8), Ester Ramos (9), Francisco Hernández-Oliveros (10), Clara Hernández-Blanco (11), Antonio Pérez-Martínez (1, 3, 12) - (1) University Hospital La Paz Research In- herapy Unit, Hematology Department, La Paz University Hospital, Spain, (6) Hematology Department, University Hospital La Paz, Spain, (7) Immunology Unit, University Hospital La Paz, Spain, (8) Nephrology Department, University Hospital La Paz, Spain, (9) Pediatric oma De Madrid, Spain 08. Healthcare-as- sociated infections, infection prevention & control 8e. Hospital epidemiology, transmis- sion, surveillance & screening (incl. environment) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13686&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0777 04. Diagnostic micro- biology 4d. Molecular diagnostics (incl. POCT and syndromic testing) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13687&preview=1&aig=-1https://online.eccmid.org/programme-live-1?coday=2023-04-15&openSession=OS013 artment Of Population Health, University Of Oxford, United Kingdom, (2) Respiratory And Vaccine Preventable Bacteria Reference Unit, Uk Health Security Agency, United Kingdom, (3) Department Of Biology, University Of Oxford, United Kingdom, (4) Antimicrobial ases, Uk Health Security Agency, United Kingdom 03. Bacterial suscepti- bility & resistance 3c. Susceptibility testing methods (incl. assay validation, phenotypic assays and comparative studies, excl. TB) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13688&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0379 illa (1), Concepción Segura (1), Núria Prim (1) - (1) Laboratori De Referència De Catalunya, Spain, (2) Hospital Del Mar, Spain, (3) Institut Del Mar D‘Investigacions Mèdiques, Spain, (4) Institute For Global Health Isglobal, Spain, (5) Universitat Pompeu Fabra (Upf), 02. Bacterial infection & disease 2f. Community acquired nervous sys- tem and other multi-system bacterial infections (incl. epidemiology, clinical, imaging, treatment & prevention) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13689&preview=1&aig=-1https://online.eccmid.org/programme-live-1?coday=2023-04-17&openSession=OS191 Maximilians University, Germany, (2) Neurosurgical Research, Department Of Neurosurgery, Klinikum Großhadern, Ludwig-Maximilians University, Germany, (3) Department Of Molecular Genetics And Infection Biology, Interfaculty Institute For Genetics And Functio- 03. Bacterial suscepti- bility & resistance 3b. Resistance surveillance & epidemio- logy: Gram-negatives https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13691&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0114 gy And Risk Analysis Applied To Veterinary Sciences (Urear-Uliège), Fundamental And Applied Research For Animal And Health (Farah) Center, University Of Liège, Belgium 13. Case reports and case series (n<10) 13b. Bacterial infections https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13692&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P3331 rsity Hospital, Czech Republic, (2) Iii. Department Of Surgery, 1St Medical Faculty, Charles University And University Hospital Motol, Czech Republic 03. Bacterial suscepti- bility & resistance 3e. Resistance detection / prediction approaches (rapid and/or molecular assays, resistome analysis, inference methods) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13693&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0493 09. Experimental microbiology, micro- bial pathogenesis & biofilm 9a. Microbial pathogenesis & virulence https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13694&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P0958 04. Diagnostic micro- biology 4d. Molecular diagnostics (incl. POCT and syndromic testing) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13695&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1686 02. Bacterial infection & disease 2f. Community acquired nervous sys- tem and other multi-system bacterial infections (incl. epidemiology, clinical, imaging, treatment & prevention) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13696&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1440 Ses, Crt, Dst/Aids, Brazil, (3) Usp, Brazil 02. Bacterial infection & disease 2b. Severe sepsis, bacteraemia & endocarditis (incl. epidemiology, diag- nosis, host bio-markers, treatment and outcome prediction) https://escmid.reg.key4events.com/AbstractList.aspx?e=17&header=0&ai=13698&preview=1&aig=-1https://online.eccmid.org/container-intervention-lookup.php?p=1&interv=P1166 hiavo (2), Mauro Codeluppi (1), Giuliana Lo Cascio (2) - (1) Hospital Of Piacenza, Infectious Diseases Unit, Italy, (2) Hospital Of Piacenza, Microbiology Unit, Italy, (3) University Of Parma, ItalyNext >